RU2471808C2 - Полипептиды модифицированного гормона роста - Google Patents

Полипептиды модифицированного гормона роста Download PDF

Info

Publication number
RU2471808C2
RU2471808C2 RU2010103159/10A RU2010103159A RU2471808C2 RU 2471808 C2 RU2471808 C2 RU 2471808C2 RU 2010103159/10 A RU2010103159/10 A RU 2010103159/10A RU 2010103159 A RU2010103159 A RU 2010103159A RU 2471808 C2 RU2471808 C2 RU 2471808C2
Authority
RU
Russia
Prior art keywords
seq
nucleic acid
acid sequence
growth hormone
amino acid
Prior art date
Application number
RU2010103159/10A
Other languages
English (en)
Russian (ru)
Other versions
RU2010103159A (ru
Inventor
Питер АРТИМЬЮК
Ричард А. РОСС
Джон СЭЙЕРС
Original Assignee
Астерион Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Астерион Лимитед filed Critical Астерион Лимитед
Publication of RU2010103159A publication Critical patent/RU2010103159A/ru
Application granted granted Critical
Publication of RU2471808C2 publication Critical patent/RU2471808C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
RU2010103159/10A 2007-10-10 2008-09-10 Полипептиды модифицированного гормона роста RU2471808C2 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US97901007P 2007-10-10 2007-10-10
US60/979,010 2007-10-10
GBGB0719818.7A GB0719818D0 (en) 2007-10-11 2007-10-11 Growth hormone fusion polypeptides
GB0719818.7 2007-10-11
PCT/GB2008/003056 WO2009047474A2 (en) 2007-10-10 2008-09-10 Modified growth hormone polypeptides

Publications (2)

Publication Number Publication Date
RU2010103159A RU2010103159A (ru) 2011-11-20
RU2471808C2 true RU2471808C2 (ru) 2013-01-10

Family

ID=38787949

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010103159/10A RU2471808C2 (ru) 2007-10-10 2008-09-10 Полипептиды модифицированного гормона роста

Country Status (17)

Country Link
US (2) US8273552B2 (cg-RX-API-DMAC7.html)
EP (2) EP2886553A1 (cg-RX-API-DMAC7.html)
JP (1) JP5697983B2 (cg-RX-API-DMAC7.html)
KR (1) KR20100067686A (cg-RX-API-DMAC7.html)
CN (1) CN101932600B (cg-RX-API-DMAC7.html)
AR (1) AR068038A1 (cg-RX-API-DMAC7.html)
AU (1) AU2008309386A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0818639A2 (cg-RX-API-DMAC7.html)
CA (1) CA2701369A1 (cg-RX-API-DMAC7.html)
DK (1) DK2209798T3 (cg-RX-API-DMAC7.html)
ES (1) ES2532600T3 (cg-RX-API-DMAC7.html)
GB (1) GB0719818D0 (cg-RX-API-DMAC7.html)
IL (1) IL203073A0 (cg-RX-API-DMAC7.html)
MX (1) MX2010003892A (cg-RX-API-DMAC7.html)
RU (1) RU2471808C2 (cg-RX-API-DMAC7.html)
TW (1) TW200918098A (cg-RX-API-DMAC7.html)
WO (1) WO2009047474A2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0606946D0 (en) * 2006-04-06 2006-05-17 Asterion Ltd Polypeptide antagonist
GB201104285D0 (en) 2011-03-15 2011-04-27 Asterion Ltd Modified receptor fusion proteins

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH20A (fr) * 1888-12-05 Joseph Magnat Une pompe à bière automatique fonctionnant par la pression de l'eau
WO2001096565A2 (en) * 2000-06-16 2001-12-20 Asterion Limited Binding agents: chimeric ligand/receptor proteins
WO2004090135A2 (en) * 2003-04-09 2004-10-21 Asterion Limited Cytokine polypeptides and antibodies containing a signal sequence for the attachement of glycosylphosphatidylinositol
RU2287533C2 (ru) * 2000-08-01 2006-11-20 Новартис Аг Аналоги соматостатина

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE455171T1 (de) * 1995-09-21 2010-01-15 Genentech Inc Varianten des menschlichen wachstumshormons
ATE509097T1 (de) 2001-11-21 2011-05-15 Us Health Gewinnung von rekombinantem menschlichem parainfluenzavirus typ 1 (hpivi) aus cdna
GB2384001B (en) * 2001-12-14 2004-02-04 Asterion Ltd Chimeric growth hormone-growth hormone receptor proteins
MX2007001180A (es) * 2004-07-26 2007-04-13 Asterion Ltd Enlazantes.
GB0717985D0 (en) 2007-07-20 2007-10-24 Asterion Ltd Growth hormone fusion proteins
EP2288386A1 (en) * 2008-02-19 2011-03-02 Asterion Limited Modified linkers

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH20A (fr) * 1888-12-05 Joseph Magnat Une pompe à bière automatique fonctionnant par la pression de l'eau
WO2001096565A2 (en) * 2000-06-16 2001-12-20 Asterion Limited Binding agents: chimeric ligand/receptor proteins
RU2287533C2 (ru) * 2000-08-01 2006-11-20 Новартис Аг Аналоги соматостатина
WO2004090135A2 (en) * 2003-04-09 2004-10-21 Asterion Limited Cytokine polypeptides and antibodies containing a signal sequence for the attachement of glycosylphosphatidylinositol

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
PRADHANANGA S.L. ET AL., TANDEM FUSIONS OF GROWTH HORMONE AND ITS G120R MUTATED ANTAGONIST RETAIN BIOLOGICAL ACTIVITY AND DEMONSTRATE PROLONGED PLASMA HALF-LIFE, GROWTH HORMONE AND IGF RESEARCH, 2004, v.14, n.2, p.116. *
Последовательность под N NRP-HC000388, размещенная 22.07.2004 в БД "FASTA EBI.AC.UK". *
Последовательность под N NRP-HC000388, размещенная 22.07.2004 в БД "FASTA EBI.AC.UK". PRADHANANGA S.L. ET AL., TANDEM FUSIONS OF GROWTH HORMONE AND ITS G120R MUTATED ANTAGONIST RETAIN BIOLOGICAL ACTIVITY AND DEMONSTRATE PROLONGED PLASMA HALF-LIFE, GROWTH HORMONE AND IGF RESEAR n.2, p.116. *

Also Published As

Publication number Publication date
CN101932600A (zh) 2010-12-29
CN101932600B (zh) 2014-05-28
BRPI0818639A2 (pt) 2015-04-07
AR068038A1 (es) 2009-10-28
EP2209798A2 (en) 2010-07-28
WO2009047474A2 (en) 2009-04-16
CA2701369A1 (en) 2009-04-16
US20100197589A1 (en) 2010-08-05
US8273552B2 (en) 2012-09-25
JP5697983B2 (ja) 2015-04-08
IL203073A0 (en) 2010-11-30
WO2009047474A3 (en) 2010-09-02
GB0719818D0 (en) 2007-11-21
JP2011507487A (ja) 2011-03-10
ES2532600T3 (es) 2015-03-30
MX2010003892A (es) 2010-05-17
DK2209798T3 (en) 2015-03-23
KR20100067686A (ko) 2010-06-21
TW200918098A (en) 2009-05-01
US20120322735A1 (en) 2012-12-20
EP2209798B1 (en) 2014-12-31
EP2886553A1 (en) 2015-06-24
AU2008309386A1 (en) 2009-04-16
RU2010103159A (ru) 2011-11-20

Similar Documents

Publication Publication Date Title
TWI760333B (zh) Gdf15融合蛋白及其用途
US8470559B2 (en) Growth hormone fusion proteins
JP2020509761A (ja) 免疫グロブリンのFc部分を含む二重標的融合タンパク質
ES2378424T3 (es) Proteína de fusión de la hormona del crecimiento
EP2314615A2 (en) Amylin family polypeptide-6 (afp-6) analogs and methods of making and using them
CN110546159A (zh) 甲状旁腺激素融合多肽
EP2209798B1 (en) Modified growth hormone polypeptides
US9493536B2 (en) Growth hormone receptor antagonists
US20090270325A1 (en) Growth factor
EP1746106A2 (en) Use of TACI as an anti-tumor agent
HK1045160A (en) Expression and export of anti-obesity proteins as fc fusion proteins
HK1103299A (en) Use of taci as an anti-tumor agent

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20140911